Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab effects on esophageal barrier function and food-induced immune responses in adult eosinophilic esophagitis
NL-OMON57371Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of dupilumab in eosinophilic esophagitis (EoE) (3 arms), sponsored by Amsterdam University Medical Center. Started Jul 2025; status: recruiting.
02
Drugs
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NL-OMON57371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57371.